E. Vilar

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose

E. Vilar, David Wellsted, Shahid M. Chandna et al. · Nephrology Dialysis Transplantation · 2009 · 167 citations · Full text

Medicine, Nephrology, Nutrition +17

Long-Term Outcomes in Online Hemodiafiltration and High-Flux Hemodialysis

E. Vilar, Andrew C. Fry, David Wellsted et al. · Clinical Journal of the American Society of Nephrology · 2009 · 163 citations

Medicine, Nephrology, Dialysis +7

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Experimental and theoretical statistics of microwave amplitude scintillations on satellite down-links

T.J. Moulsley, E. Vilar · IRE Transactions on Antennas and Propagation · 1982 · 101 citations

Engineering, Earth Sciences, Electrical Engineering +13